Wei Jia

机构：Hangzhou First People's Hospital · ORCID：0000-0003-1248-4519

发表论文 76 篇 · 总被引 1331 次 · h-index 22

代表论文

• ETV5-mediated upregulation of lncRNA CTBP1-DT as a ceRNA facilitates HGSOC progression by regulating miR-188-5p/MAP3K3 axis (2021 · Cell Death and Disease · 被引 29)
• IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma (2021 · BMC Cancer · 被引 20)
• Knockdown of SENP1 inhibits HIF-1α SUMOylation and suppresses oncogenic CCNE1 in Wilms tumor (2021 · Molecular Therapy — Oncolytics · 被引 16)
• Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma (2022 · BMC Genomics · 被引 12)
• Efficacy and safety of intermittent versus continuous dose apatinib plus docetaxel as second-line therapy in patients with advanced gastric cancer or gastroesophageal junction adenocarcinoma: a randomized controlled study (2022 · Annals of Translational Medicine · 被引 8)
• CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2α deubiquitination (2025 · Neoplasia · 被引 7)